Kalah Auchincloss, senior vice-president and deputy general counsel, Greenleaf Health, Inc.
FDA Inspections During COVID-19: A Brave New World
This article explores the evolution of FDA’s approach to inspections of drug and biologics manufacturing facilities during the COVID-19 pandemic.